Activation of Wnt/β-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice

Hepatology

Volumn 44, Issue 4, 2006, Pages 992-1002

  Apte, Udayan ^a   Zeng, Gang ^a   Muller, Peggy ^a   Tan, Xinping ^a   Micsenyi, Amanda ^a   Cieply, Benjamin ^a   Dai, Chunsun ^a   Liu, Youhua ^a   Kaestner, Klaus H ^b   Monga, Satdarshan P S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; WNT PROTEIN; CADHERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE TARGETING; HEPATOMEGALY; LIVER CELL; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENE TRANSFER; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; MOUSE STRAIN; PATHOLOGY; PLASMID; PROMOTER REGION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANIMALS; BETA CATENIN; CADHERINS; GENE TRANSFER TECHNIQUES; HEPATOCYTE GROWTH FACTOR; HEPATOCYTES; HEPATOMEGALY; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 33750610840     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21317     Document Type: Article

References (31)

1. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276:60-66.
2. Ishikawa KS, Masui T, Ishikawa K, Shiojiri N. Immunolocalization of hepatocyte growth factor and its receptor (c-Met) during mouse liver development. Histochem Cell Biol 2001;116:453-462.
3. Nagy P, Bisgaard HC, Santoni-Rugiu E, Thorgeirsson SS. In vivo infusion of growth factors enhances the mitogenic response of rat hepatic ductal (oval) cells after administration of 2-acetylaminofluorene. HEPATOLOGY 1996;23:71-79.
4. Pediaditakis P, Lopez-Talavera JC, Petersen B, Monga SP, Michalopoulos GK. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. HEPATOLOGY 2001; 34: 688-693.
5. Fausto N. Liver regeneration. J Hepatol 2000; 32:19-31.
6. Apte UM, Limaye PB, Ramaiah SK, Vaidya VS, Bucci TJ, Warbritton A, et al. Upregulated promitogenic signaling via cytokines and growth factors: potential mechanism of robust liver tissue repair in calorie-restricted rats upon toxic challenge. Toxicol Sci 2002;69:448-459.
7. Yamaguchi K, Nalesnik MA, Michalopoulos GK. Hepatocyte growth factor mRNA in human liver cirrhosis as evidenced by in situ hybridization. Scand J Gastroenterol 1996;31:921-927.
8. Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. HEPATOLOGY 1995;21:106-112.
9. Vejchapipat P, Tangkijvanich P, Theamboonlers A, Chongsrisawat V, Chittmittrapap S, Poovorawan Y. Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma. J Gastroenterol 2004;39:1182-1188.
10. Burr AW, Hillan KJ, McLaughlin KE, Ferrier R, Chapman C, Mathew J, et al. Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis. HEPATOLOGY 1996;24:1282-1287.
11. Bell A, Chen Q, DeFrances MC, Michalopoulos GK, Zarnegar R. The five amino acid-deleted isoform of hepatocyte growth factor promotes carcinogenesis in transgenic mice. Oncogene 1999;18:887-895.
12. Monga SPS, Michalopoulos GK. The Wnt/β-cateninenin pathway. In: Dufour JF, Clavien PA,. eds. Signaling Pathways in Liver Disease. 1st ed. New York: Springer, 2005:173-193.
13. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A 1998;95:8847-8851.
14. Devereux TR, Anna CH, Foley JF, White CM, Sills RC, Barrett JC. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis. Oncogene 1999;18:4726-4733.
15. Wei Y, Fabre M, Branchereau S, Gauthier F, Perilongo G, Buendia MA.. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Oncogene 2000;19:498-504.
16. Micsenyi A, Tan X, Sneddon T, Luo JH, Michalopoulos GK, Monga SP. Beta-catenin is temporally regulated during normal liver development. Gastroenterology. 2004;126:1134-46.
17. Monga SP, Pediaditakis P, Mule K, Stolz DB, Michalopoulos GK. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. HEPATOLOGY 2001;33:1098-1109.
18. Yang J, Chen S, Huang L, Michalopoulos GK, Liu Y. Sustained expression of naked plasmid DNA encoding hepatocyte growth factor in mice promotes liver and overall body growth. HEPATOLOGY 2001;33:848-859.
19. Tan X, Apte U, Micsenyi A, Kotsagrelos E, Luo JH, Ranganathan S, et al. Epidermal Growth Factor Receptor: A novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology 2005;129:285-302.
20. Monga SP, Mars WM, Pediaditakis P, Bell A, Mule K, Bowen WC, et al. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res 2002;62:2064-2071.
21. Papkoff J, Aikawa M. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells. Biochem Biophys Res Commun 1998;247:851-858.
22. Fischer OM, Giordano S, Comoglio PM, Ullrich A. Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells. J Biol Chem 2004;279:28970-28978.
23. Noe V, Chastre E, Bruyneel E, Gespach C, Mareel M. Extracellular regulation of cancer invasion: the E-cadherin-catenin and other pathways. Biochem Soc Symp 1999;65:43-62.
24. Gotoh J, Obata M, Yoshie M, Kasai S, Ogawa K. Cyclin D1 over-expression correlates with beta-catenin activation, but not with H-ras mutations, and phosphorylation of Akt, GSK3 beta and ERK1/2 in mouse hepatic carcinogenesis. Carcinogenesis 2003;24:435-442.
25. Anna CH, Iida M, Sills RC, Devereux TR. Expression of potential beta catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice. Toxicol Appl Pharmacol 2003;190:135-145.
26. Davies G, Jiang WG, Mason MD. HGF/SF modifies the interaction between its receptor c-Met, and the E-cadherin/catenin complex in prostate cancer cells. Int J Mol Med 2001;7:385-388.
27. Calvisi DF, Ladu S, Conner EA, Factor VM, Thorgeirsson SS. Disregulation of E-cadherin in transgenic mouse models of liver cancer. Lab Invest 200484:1137-1147.
28. Prange W, Breuhahn K, Fischer F, Zilkens C, Pietsch T, Petmecky K, et al. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes. J Pathol 2003;201: 250-259.
29. Endo K, Ueda T, Ueyama J, Ohta T, Terada T. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum Pathol 2000;31:558-565.
30. Haegel H, Larue L, Ohsugi M, Fedorov L, Herrenknecht K, Kemler R. Lack of beta-catenin affects mouse development at gastrulation. Development 1995;121:3529-3537.
31. Brault V, Moore R, Kutsch S, Ishibashi M, Rowitch DH, McMahon AP, et al. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development Development 2001;128:1253-1264.